Evidence map›Paper›PMID 30778754›Full record

ArticleParasitology research2019

Heterogeneity of humoral immune response to Leishmania tropica in an experimental model.

Mosayeb Rostamian, Alisha Akya, Hamid M Niknam

Abstract read
PubMed Publisher
In one paragraph

Article in Parasitology research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Effect ofChinese herbal medicines · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Mosayeb RostamianInfectious Diseases Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Alisha AkyaInfectious Diseases Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Hamid M NiknamImmunology Department, Pasteur Institute of Iran, 69 Pasteur Avenue, Tehran, 13169-43551, Iran. hamid.m.niknam@gmail.com.ORCID http://orcid.org/0000-0001-9338-4266
Kermanshah University of Medical Sciences · IRPasteur Institute of Iran · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Humoral (antibody) response is an important part of immunity against pathogens. Despite the clear role of cell-mediated immune response in protection against leishmaniasis, the role of humoral responses is challenging. There is very limited data regarding humoral immune response against Leishmania tropica which is the causative agent of human cutaneous leishmaniasis in many parts of the world. Here, we have compared pathogenicity and antibody response against six Iranian Leishmania tropica isolates in BALB/c mice. A Leishmania major isolate was used for comparison. The parasites were injected into the mice followed by the evaluation of the lesion development, parasite load, and antibody responses (IgG1 and IgG2a). Our findings showed that some isolates caused the large lesions and high parasite load in the spleen and lymph node, while other isolates led to no lesion, no splenic parasitism, and low parasite load in the lymph node. The more pathogenic isolates induced higher antibody responses (IgG1 and IgG2a). Our results indicated that there is substantial heterogeneity among various Leishmania tropica isolates regarding the humoral immune response as well as the pathogenicity.

Indexed as

AnimalsAntibodies, ProtozoanDisease Models, AnimalHumansImmunity, HumoralImmunoglobulin GIranLeishmania majorLeishmaniasis, CutaneousLeishmania tropicaLymph NodesMiceMice, Inbred BALB CParasite LoadSpleenAntibodies, ProtozoanImmunoglobulin GAntibodyIranLeishmania tropicaLesion sizeParasite load

Identifiers

PMID30778754
OpenAlexW2916858356

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.